An open-label, multiple-dose, two-treatment period study to evaluate the effect of oral BAF312 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female volunteers

Trial Profile

An open-label, multiple-dose, two-treatment period study to evaluate the effect of oral BAF312 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Aug 2014

At a glance

  • Drugs Siponimod (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications Multiple sclerosis; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 22 Sep 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 17 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top